Medicare Advantage Payments Increase by 2.48%, Boosting Insurer Stocks
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 07 2026
0mins
Should l Buy UNH?
Source: seekingalpha
- Payment Increase Impact: The Centers for Medicare & Medicaid Services announced a 2.48% increase in Medicare Advantage payments for 2027, leading to significant stock price surges among major healthcare insurers in after-hours trading on Monday, reflecting market optimism regarding insurers' profitability.
- Significant Market Reaction: Following this announcement, Centene Corporation (CNC) saw a 4.3% increase, UnitedHealth Group (UNH) rose by 7.8%, and Humana (HUM) surged by 11%, indicating heightened investor confidence in the healthcare insurance sector's outlook.
- Quantitative Rating Insights: According to Quant ratings, HealthEquity (HQY) leads with a score of 3.57, followed by Centene (3.38) and Alignment Healthcare (3.30), providing investors with valuable insights for selecting insurance providers based on performance metrics.
- Future Outlook: This payment increase is expected to generate an additional $18 billion in revenue for insurers, further driving industry growth while potentially influencing future premium rates and benefit structures, thereby enhancing the competitive positioning of insurance companies.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy UNH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on UNH
Wall Street analysts forecast UNH stock price to rise
19 Analyst Rating
16 Buy
3 Hold
0 Sell
Strong Buy
Current: 324.630
Low
330.00
Averages
397.82
High
444.00
Current: 324.630
Low
330.00
Averages
397.82
High
444.00
About UNH
UnitedHealth Group Incorporated is a healthcare and well-being company. Its segments include Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare, which includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement and UnitedHealthcare Community & State. Optum Health provides comprehensive and patient-centered care, addressing the physical, mental, and social well-being. Optum Health delivers primary, specialty and surgical care and helps patients and providers navigate and address complex, chronic and behavioral health needs. Optum Insight connects the healthcare system with services, analytics and platforms that make clinical, administrative and financial processes simpler and more efficient for all participants in the healthcare system. Optum Rx offers a range of pharmacy care services through retail pharmacies, through home delivery, specialty and community health pharmacies and the provision of in-home and community-based infusion services.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Earnings Forecast Adjustment: Piper Sandler reiterated an 'Overweight' rating and raised its price target to $399, implying a 23% upside from current levels, with expected 2026 EPS at $17.79, aligning with company guidance, reflecting market confidence in UnitedHealth's future profitability.
- Payment Pressure: Despite bullish analyst updates, revisions to Medicare Advantage reimbursements remain a major swing factor for earnings recovery, with an estimated $6 billion impact on revenue through 2026, highlighting the company's vulnerability in the Medicare sector.
- Optum Health's Importance: UnitedHealth's turnaround narrative increasingly hinges on Optum Health's performance, which exited Medicare Advantage plans in 109 counties affecting 180,000 members; however, the company claims to have entered 2026 on a stronger foundation, emphasizing its focus on future profitability.
- Investor Sentiment Shift: Retail sentiment for UnitedHealth surged from neutral to bullish on Stocktwits, with message volumes increasing over 1,150%, indicating heightened market interest in the upcoming earnings report and guidance, potentially driving stock price rebounds in the coming months.
See More
- Payment Acceleration Program: UnitedHealthcare's Rural Payment Acceleration Pilot, launched in January 2026, reduces Medicare Advantage payment times from 30 days to under 15 days for approximately 1,500 rural hospitals, significantly enhancing cash flow and financial sustainability.
- Authorization Requirement Exemption: By fall 2026, UnitedHealthcare will exempt most medical prior authorization requirements for about 1,500 rural hospitals and their practitioners, alleviating cost and staffing pressures and allowing providers to focus more on patient care.
- Hub-and-Spoke Model: UnitedHealthcare is partnering with leading health systems to implement hub-and-spoke care models that enhance continuity of care in rural areas, focusing initially on maternity care, diabetes, and post-surgical care through advanced mobile and virtual care capabilities.
- Ongoing Investment Commitment: UnitedHealthcare is committed to further investments in rural healthcare, ensuring that these vulnerable providers receive the necessary support to deliver quality care to local residents, thereby enhancing their financial stability.
See More
- Apple CEO Transition: Tim Cook will step down as CEO of Apple on September 1, with John Ternus taking over; under Cook's leadership since August 2011, Apple's stock has surged approximately 2000%, indicating strong growth during his tenure.
- Market Performance: Apple's stock has risen 38% over the past year, although it remains relatively flat in after-hours trading, reflecting a mix of market anticipation and uncertainty regarding the new CEO's impact.
- Aviation Industry Challenges: Alaska Air CEO Ben Minicucci will discuss the impact of high jet fuel prices on the airline industry in an interview tomorrow; despite an 18% stock increase in April, shares are down 13% year-to-date, highlighting ongoing industry pressures.
- Defense Company Dynamics: Northrop Grumman and RTX have seen flat stock performance over the past three months, but Northrop's stock has dropped 9% since the onset of the Iran conflict, while RTX is down 3%, illustrating the geopolitical effects on the defense sector.
See More
- Elimination of Authorization Requirements: UnitedHealth Group has announced the end of most medical prior authorization requirements, particularly for rural providers, thereby reducing administrative burdens and enhancing service efficiency.
- Accelerated Payment Processes: The company stated that payments to rural hospitals and providers will arrive up to 50% faster, directly improving cash flow for approximately 1,500 hospitals and enhancing their operational capabilities.
- Enhanced Access to Care: Through these reforms, UnitedHealth aims to lower healthcare costs and simplify processes, significantly increasing access to quality care for individuals in rural communities, aligning with its corporate social responsibility goals.
- Promotion of Regional Healthcare Collaboration: UnitedHealth is also working with health systems to facilitate hub-and-spoke care models, connecting regional clinical experts with community-based facilities, further enhancing the accessibility and quality of healthcare services.
See More
- Positive Bank Performance: Bank stocks kicked off earnings season last week, with the State Street SPDR S&P Bank ETF (KBE) gaining over 2% and marking its fifth consecutive winning week, indicating strong market leadership and potentially boosting investor confidence.
- Focus on Defense Stocks: Jay Woods highlighted that the three largest components of the iShares U.S. Aerospace & Defense ETF (ITA)—GE, RTX, and Boeing—are set to report earnings, with ITA climbing over 7% in 2026, on track for its sixth consecutive profitable year, showcasing the strength of the defense sector.
- ServiceNow Recovery Potential: ServiceNow shares have tumbled more than 35% in 2026, making it one of the worst performers in the S&P 500, but analysts believe the sell-off is overdone, with an average price target suggesting over 72% upside, making it a stock to watch.
- UnitedHealth Stock Analysis: UnitedHealth's stock has fallen over 29% in the past year, yet it is currently trading above its 200-day moving average; Woods noted that if it holds above $324 per share, it could see upside towards $353.75, while downside risks could see it drop to $300 or $287.
See More
- Honeywell Business Sale: Honeywell sells its Productivity Solutions and Services (PSS) business to Brady Corporation for $1.4 billion in cash, a strategic move to divest cyclical, slower-growing, lower-margin operations, thereby enhancing the overall quality of its portfolio.
- Market Reaction Stable: Despite a 5% rise in oil prices due to uncertainty over commercial shipping traffic in the Strait of Hormuz, the market's decline was less severe than feared, as Treasury yields remained relatively unchanged, indicating a stable investor sentiment.
- Eli Lilly Acquisition Moves: Eli Lilly acquires clinical-stage biotech firm Kelonia Therapeutics for $3.25 billion in cash, aiming to bolster its cancer treatment pipeline, with the deal potentially worth up to $7 billion, showcasing the company's aggressive expansion strategy in oncology.
- Active IPO Market: In spite of uncertainties from the Iran conflict, Jersey Mike's confidentially files for an IPO with a valuation of approximately $8 billion, reflecting ongoing interest in new public offerings and further driving growth in investment banking activities.
See More











